Local matrix metalloprotease-8 and neutrophils in the airways of tobacco smokers with or without chronic bronchitis Source: Eur Respir J 2003; 22: Suppl. 45, 207s Year: 2003
Cigarette smoking inhibits LTA4 H aminopeptidase activity and contributes to chronic neutrophilic airway inflammation and COPD Source: Annual Congress 2011 - COPD: clinical studies and animal cell models Year: 2011
Imbalance between leukoprotease inhibitor levels and neutrophils in BAL from smokers with chronic bronchitis and recurrent exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001
Measurement of neutrophil activity following acute cigarette smoking in heavy smokers with and without COPD Source: Annual Congress 2007 - Molecular pathogenesis: focus on COPD and asthma Year: 2007
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
CC10 and TIMP1 levels in induced sputum of smokers who developed chronic airflow impairment Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005
Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM) Source: Eur Respir J 2003; 22: Suppl. 45, 85s Year: 2003
MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012
Airway epithelial cells from asymptomatic smokers but not from smokers with chronic bronchitis and COPD have increased C/EBP transcription factor activity Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Bacterial infection, IL-8 and elastase activity in children with chronic bronchiolitis and bronchial asthma in stable period Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003
Erythromycin inhibits neutrophil extracellular traps in smoking-related chronic pulmonary inflammation Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Source: Eur Respir J 2005; 26: 835-845 Year: 2005
Measurement of in situ inflammatory cell activity in the lungs of patients with COPD or asthma Source: Eur Respir J 2002; 20: Suppl. 38, 267s Year: 2002
Roflumilast significantly decreased inflammatory biomarkers in induced sputum in current smokers patients with severe chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis Source: Eur Respir J 2007; 30: 467-471 Year: 2007
Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation? Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Elevation of surfactant protein A in plasma and sputum in cigarette smokers Source: Eur Respir J 2011; 38: 277-284 Year: 2011